基于纳米酶的治疗策略用于类风湿性关节炎
Jucong Zhang1, Chenxi Wang2, Xiaochuan Wu1
1Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
概括
纳米酶为风湿性关节炎 (RA) 提供了一种新的治疗方法,通过模仿自然酶来减少炎症和氧化应激. 这些纳米材料有望改善RA治疗和患者的治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,会导致关节损伤和残疾.
- 目前的RA治疗方法在疗效和副作用方面存在局限性.
- 纳米酶,具有类似酶活性的纳米材料,呈现出一种新的治疗途径.
研究的目的:
- 审查基于纳米酶的类风湿性关节炎治疗的最新进展.
- 专注于RA中纳米酶的抗氧化和免疫调节功能.
- 探索涉及纳米酶的组合疗法,以加强RA治疗.
主要方法:
- 关于治疗类风湿性关节炎的纳米酶的文献综述.
- 纳米酶根据材料的分类 (例如,,铁,,银,铜,白金,,多金属).
- 对纳米酶机制的分析,包括模仿超氧化物脱酶,酶和过氧化酶.
主要成果:
- 纳米酶有效地减少RA模型中的氧化应激和炎症.
- 各种纳米酶显示出显著的治疗潜力.
- 使用囊泡和光疗的组合疗法增强了纳米酶的疗效.
结论:
- 纳米酶代表了对类风湿性关节炎的有前途的治疗策略.
- 它们的抗氧化和免疫调节特性比传统治疗方法具有优势.
- 对基于纳米酶的治疗方法的进一步研究可能会导致改善RA的临床应用.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Ribozymes
11.2K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
11.2K


